fluoxetine has been researched along with moclobemide in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (57.63) | 18.2507 |
| 2000's | 12 (20.34) | 29.6817 |
| 2010's | 11 (18.64) | 24.3611 |
| 2020's | 2 (3.39) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J | 1 |
| Bhosale, SH; Shelke, SM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Burrows, GD; Judd, FK; Norman, TR | 1 |
| Campeas, R; Fallon, BA; Feerick, J; Gitow, A; Hollander, E; Liebowitz, MR; Saoud, JB; Schneier, FR; Street, L; Welkowitz, LA | 1 |
| Coulter, DM; Pillans, PI | 1 |
| Hackett, LP; Ilett, KF; Pinder, M; Power, BM | 1 |
| Gattaz, WF; Kick, H; Kohnen, R; Vogel, P | 1 |
| Haazen, L; Janne, P; Mirel, J; Parent, M; Reynaert, C | 1 |
| Kiviruusu, O; Lonnqvist, J; Pitkanen, H; Sihvo, S; Sintonen, H; Syvälahti, E | 1 |
| Blier, P; De Montigny, C; Mongeau, R | 1 |
| Pétursson, H | 1 |
| Kiviruusu, O; Lonnqvist, J; Sihvo, S; Syvälahti, E | 1 |
| Lapierre, YD | 1 |
| Hickie, I; Wilson, A | 1 |
| Bruynooghe, F; De Cuyper, H; Demeulemeester, F; Geerts, S; Haazen, L | 1 |
| Fallon, BA; Feerick, J; Liebowitz, MR; Marshall, RD; Schneier, FR | 1 |
| Appelberg, B; Auvinen, J; Koskinen, T; Lonnqvist, J; Mannikko, T; Mehtonen, OP; Naarala, M; Sihvo, S; Sintonen, H; Syvälahti, E | 1 |
| Fawcett, JP; Menkes, DB; Patel, PP | 1 |
| Edwards, RA; Menkes, DB; Mullen, R; Newburn, GM; Segkar, C; Williams, R | 1 |
| LaBranche, S | 1 |
| Dollow, S | 1 |
| Benazzi, F | 1 |
| Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Ratnam, S | 1 |
| Lönnqvist, J; Partonen, T | 1 |
| Annable, L; Beauclair, L; Bland, R; Chouinard, G; Ingram, P; Joffe, R; Kennedy, S; Lapierre, YD; McKenna, K; Reesal, R; Rickhi, BG | 1 |
| Behnke, K; Bouwer, C; Tiller, JW | 2 |
| Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A | 1 |
| Bergqvist, PB; Blier, P; Bouchard, C | 1 |
| Ramasubbu, R | 1 |
| Meyers, BS | 1 |
| Angst, J; Delini-Stula, A; Stassen, HH | 1 |
| Advenier, C; Alvarez, JC; Sanceaume, M; Spreux-Varoquaux, O | 1 |
| Chambost, M; Combe, C; Liron, L; Peillon, D | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Baier, D; Kohnen, R; Philipp, M; Tiller, JW | 1 |
| van de Laar, MA; Zijlstra, TR | 1 |
| Sakamoto, K | 1 |
| Huang, WC; Li, YF; Liu, YQ; Luo, ZP | 1 |
| Barros, HM; Gomez, R; Kopittke, L | 1 |
| Aker, T; Onder, E; Tural, U | 1 |
| Cryan, JF; Lucki, I; Page, ME | 1 |
| Cao, JB; Guan, TT; Li, YF; Liu, YQ; Luo, ZP; Wang, HL; Zhang, YZ | 1 |
| Bogo, MR; Bonan, CD; Cognato, Gde P; Henz, SL; Sarkis, JJ; Vuaden, FC | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Aswar, UM; Bhosale, SH; Bodhankar, SL; Kalshetti, PP; Shelke, SM | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Beaulieu, JM; Chahine, M; Poulin, H; Thériault, O | 1 |
| Bryk, A; Bryniarski, P; Filipczak-Bryniarska, I; Kozlowski, M; Kuszmiersz, P; Myszka, M; Nazimek, K; Nowakowski, J; Strobel, S; Tyszka, A | 1 |
| Bhosale, SH; Kanhed, AM; Kulkarni, VM; Suryawanshi, MR; Yadav, MR | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
6 review(s) available for fluoxetine and moclobemide
| Article | Year |
|---|---|
New pharmacological approaches to the management of depression: from theory to clinical practice.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Fluoxetine; Humans; Moclobemide; Pyridazines; Pyrrolidinones; Rolipram; Second Messenger Systems | 1992 |
Pharmacological therapy of dysthymia.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzamides; Benzodiazepines; Depressive Disorder; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Placebos; Ritanserin; Selective Serotonin Reuptake Inhibitors | 1994 |
Medication therapy for social phobia.
Topics: Benzamides; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1994 |
[New antidepressive agents].
Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
[Seasonal affective disorder].
Topics: Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Phototherapy; Reference Standards; Seasonal Affective Disorder; Seasons; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors | 2003 |
16 trial(s) available for fluoxetine and moclobemide
| Article | Year |
|---|---|
Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1995 |
Moclobemide versus fluoxetine for a major depressive episode.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Sexual Dysfunctions, Psychological; Time Factors | 1995 |
Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression.
Topics: Acute Disease; Adult; Antidepressive Agents; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Finland; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Moclobemide; Personality Inventory; Quality of Life; Recurrence; Treatment Outcome | 1995 |
Moclobemide and fluoxetine in atypical depression: a double-blind trial.
Topics: Adult; Anticonvulsants; Benzamides; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Severity of Illness Index; Treatment Outcome | 1994 |
Moclobemide versus fluoxetine for major depressive episodes.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Psychiatric Status Rating Scales | 1994 |
Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
Topics: Adult; Benzamides; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Quality of Life | 1994 |
A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Inventory | 1993 |
Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
Topics: Adult; Benzamides; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nausea; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 1996 |
Moclobemide and fluoxetine in treatment of seasonal affective disorder.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Finland; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Inventory; Seasonal Affective Disorder; Treatment Outcome | 1996 |
Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Treatment Outcome | 1997 |
Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
Topics: Adult; Anxiety; Benzamides; Blood Pressure; Female; Fluoxetine; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors | 1997 |
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Models, Statistical; Psychiatric Status Rating Scales; Time Factors | 1999 |
Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Topics: Adult; Benzamides; Double-Blind Method; Female; Fluoxetine; Headache; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 1999 |
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors | 2000 |
A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Disasters; Female; Fluoxetine; Humans; Male; Moclobemide; Psychiatric Status Rating Scales; Severity of Illness Index; Stress Disorders, Post-Traumatic; Thiazepines; Time Factors; Treatment Outcome; Turkey | 2006 |
37 other study(ies) available for fluoxetine and moclobemide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors.
Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship | 2009 |
Synthesis, antidepressant evaluation and QSAR studies of novel 2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylthio)-N-(substituted phenyl)acetamides.
Topics: Acetamides; Animals; Antidepressive Agents; Linear Models; Mice; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
If at first you do succeed.
Topics: 1-Naphthylamine; Antidepressive Agents; Benzamides; Depression; Fluoxetine; Half-Life; Humans; Moclobemide; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1991 |
Treatment of social phobia with drugs other than benzodiazepines.
Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Humans; Male; Moclobemide; Phenelzine; Phobic Disorders; Placebos | 1991 |
Hypertension with moclobemide.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Cohort Studies; Drug Interactions; Female; Fluoxetine; Humans; Hypertension; Infant, Newborn; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors | 1995 |
Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Disseminated Intravascular Coagulation; Drug Overdose; Fatal Outcome; Female; Fever; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Multiple Organ Failure; Selective Serotonin Reuptake Inhibitors; Syndrome | 1995 |
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
Topics: Animals; Antidepressive Agents; Benzamides; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; In Vitro Techniques; Male; Maprotiline; Moclobemide; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Trimipramine | 1994 |
Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.
Topics: Benzamides; Depressive Disorder; Fluoxetine; Humans; Imipramine; Moclobemide; Monoamine Oxidase Inhibitors; Placebos; Treatment Outcome | 1995 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; Comorbidity; Female; Fluoxetine; Humans; Male; Mental Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Phobic Disorders; Prevalence | 1994 |
A catecholamine model of fatigue.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Benzamides; Brain; Catecholamines; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue Syndrome, Chronic; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors | 1994 |
Antidepressant treatment and chemical sympathectomy fail to modulate alpha 1-adrenoceptor sensitivity in mouse eye.
Topics: Administration, Topical; Amitriptyline; Animals; Antidepressive Agents; Benzamides; Desipramine; Down-Regulation; Fluoxetine; Injections, Intraperitoneal; Male; Methoxamine; Mice; Moclobemide; Oxidopamine; Phentolamine; Phenylephrine; Prazosin; Pupil; Receptors, Adrenergic, alpha-1; Sympathectomy, Chemical; Time Factors | 1993 |
Antidepressant-associated fatal intrahepatic cholestasis.
Topics: Animals; Antidepressive Agents; Benzamides; Cholestasis, Intrahepatic; Fluoxetine; Humans; Moclobemide | 1996 |
Serotonin syndrome with moclobemide-fluoxetine combination.
Topics: Adult; Benzamides; Central Nervous System Diseases; Drug Therapy, Combination; Female; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors | 1996 |
Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder.
Topics: Animals; Antidepressive Agents; Benzamides; Brain; Electroconvulsive Therapy; Fluoxetine; Guinea Pigs; Male; Moclobemide; Obsessive-Compulsive Disorder; Serotonin; Time Factors | 1999 |
Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Brain; Caudate Nucleus; Clomipramine; Drug Administration Schedule; Fluoxetine; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred Strains; Moclobemide; Raphe Nuclei; Serotonin; Time Factors; Tryptophan | 1999 |
[Serotonin syndrome during fluoxetine poisoning in a patient taking moclobemide].
Topics: Adult; Anesthetics, Intravenous; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Female; Fentanyl; Fluoxetine; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiopental | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
The lack of a placebo effect in a trial of fluoxetine in the treatment of fibromyalgia.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Female; Fibromyalgia; Fluoxetine; Humans; Moclobemide; Placebo Effect; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Cytoprotective effect is one of common action pathways for antidepressants.
Topics: Animals; Anticonvulsants; Calcium; Cell Survival; Corticosterone; Desipramine; Fluoxetine; Moclobemide; Nerve Growth Factor; Neuroprotective Agents; PC12 Cells; Rats; RNA, Messenger | 2003 |
Opposite effects of antidepressants on unstimulated and stimulated salivary flow.
Topics: Amylases; Animals; Antidepressive Agents; Calcium; Fluoxetine; Imipramine; Male; Moclobemide; Muscarinic Agonists; Phosphates; Pilocarpine; Rats; Rats, Wistar; Saliva; Salivary Proteins and Peptides; Salivation; Xerostomia | 2005 |
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Fluoxetine; Male; Moclobemide; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming | 2005 |
Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Calcium; Calcium Signaling; Cell Survival; Desipramine; Excitatory Amino Acid Antagonists; Fluoxetine; Hippocampus; L-Lactate Dehydrogenase; Moclobemide; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Nitric Oxide Synthase Type I; PC12 Cells; Rats; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tetrazolium Salts; Thiazoles | 2006 |
Influence of antidepressant drugs on Ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs) from salivary glands of rats.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cells, Cultured; Fluoxetine; Hydrolysis; Imipramine; Male; Moclobemide; Phosphoric Diester Hydrolases; Phosphorylation; Pyrophosphatases; Rats; Rats, Wistar; Salivary Proteins and Peptides; Submandibular Gland; Thymidine Monophosphate; Time Factors | 2009 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Topics: Acetamides; Acetanilides; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Imipramine; Male; Moclobemide; Olfaction Disorders; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Triazines | 2012 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Topics: Analgesics; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Membrane Potentials; Moclobemide; Monoamine Oxidase Inhibitors; NAV1.7 Voltage-Gated Sodium Channel; NAV1.8 Voltage-Gated Sodium Channel; Paroxetine; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Time Factors; Transfection | 2015 |
Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.
Topics: Animals; Antidepressive Agents; Biomarkers; Cytokines; Depressive Disorder; Dermatitis, Contact; Fluoxetine; Imipramine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Injections, Intraperitoneal; Macrophages; Male; Mice; Mice, Inbred Strains; Moclobemide; Venlafaxine Hydrochloride | 2016 |
Design, synthesis, and computational studies of phenylacetamides as antidepressant agents.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Fluoxetine; Hindlimb Suspension; Mice; Moclobemide; Swimming | 2022 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |